HLA-G: Immunoregulatory molecule involved in allograft acceptance;HLA-G: Une molécule immunorégulatrice impliquée dans l'acceptation d'organe

Nephrologie

Volumn 24, Issue 8, 2003, Pages 451-456

  Creput, C ^a   Durrbach, A ^b   Charpentier, B ^b   Carosella, E D ^a   Rouas Freiss, Nathalie ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

HLA G; Kidney; Liver; MHC class I; Tolerance; Transplantation

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLOGENEIC RESTRICTION; ALLOGRAFT; ALLOTRANSPLANTATION; ANTIGEN EXPRESSION; CELL MATURATION; CELL PROLIFERATION; CYTOTOXICITY; DENDRITIC CELL; GENETIC POLYMORPHISM; GRAFT REJECTION; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; KIDNEY TRANSPLANTATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; ORGAN TRANSPLANTATION; REVIEW; T LYMPHOCYTE; TH2 CELL;

CYTOKINES; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; LIVER TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0346881668     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220-3.
2. Paul P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, Quiles RM, Bermond F, Dausset J, Carosella ED. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol. 2000; 61: 1138-49.
3. Khalil-Daher I, Riteau B, Menier C, Sedlik C, Paul P, Dausset J, Carosella ED, Rouas-Freiss N. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J Reprod Immunol 1999; 43: 175-82.
4. Ugolini S, Vivier E. Regulation of T cell function by NK cell receptors for classical MHC class I molecules. Curr Opin Immunol 2000; 12; 295-300.
5. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001; 166: 5018-26.
6. Marchal-Bras-Goncalves R, Rouas-Freiss N, Connan F, Choppin J, Dausset J, Carosella ED, Kirszenbaum M, Guillet JG. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 2001; 33: 2355-9.
7. Rouas-Freiss N, Marchal-Bras Goncalves R, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997; 94: 11520-5.
8. Ponte M, Cantoni C, Biassoni R, Tradori-Cappai A, Bentivoglio G, Vitale C, Bertone S, Moretta A, Moretta L, Mingari MC. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc Natl Acad Sci USA 1999; 96: 5674-9.
9. Schleinitz N, Lopez F, Vely F, Vivier E. Cellules natural killer: tuer ou ne pas tuer. Med/sci 2001; 17: 504-9.
10. Dorling A, Monk NJ, Lechler RI. HLA-G inhibits the transendothelial migration of human NK cells. Eur J Immunol 2000; 30: 586-93.
11. Le Gal F-A, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet J-G, Carosella ED, Rouas-Freiss N. HLA-G mediated-inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 1999; 11: 1351-6.
12. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, Bensussan A, Le Bouteiller P. Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000; 164: 6100-4.
13. Rebmann V, Pfeiffer K, Passler M, Ferrone S, Maier S, Weiss E, Grosse-Wilde H. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tissue Antigens 1999; 53: 14-22.
14. Riteau B, Menier C, Khalil-Daher I, Sedlik C, Dausset J, Rouas-Freiss N, Carosella ED. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999; 43: 203-11.
15. Bainbridge DR, Ellis SA, Sargent IL. HLA-G suppresses proliferation of CD4(+) T-lymphocytes. J Reprod Immunol 2000; 48: 17-26.
16. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED. Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the alloproliferative response: A CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 2001; 98: 12150-5.
17. Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 1999; 11: 803-11.
18. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14: 353-6.
19. Lefebvre S, Berrih-Aknin S, Adrian F, Moreau P, Poea S, Gourand L, Dausset J, Carosella ED, Paul P. A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatiry factor 1 and mediates enhancement of this nonclassical class I gene by IFN-β. J Biol Chem 2000; 276: 6133-9.
20. Lefebvre S, Adrian F, Moreau P, Gourand L, Dausset J, Berrih-Aknin S, Carosella ED, Paul P. Modulation of HLA-G expression in human thymic and amniotic epithelial cells. Human Immunol 2000; 61: 1095-101.
21. Maejima M, Fujii T, Kozuma S, Okai T, Shibata Y, Taketani Y. Presence of HLA-G-expressing cells modulates the ability of peripheral blood mononuclear cells to release cytokines [see comments]. Am J Reprod Immunol 1997; 38: 79-82.
22. Kanai T, Fujii T, Unno N, Yamashita T, Hyodo H, Miki A, Hamai Y, Kozuma S, Taketani Y. Human leukocyte antigen-G-expressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. AJRI 2001; 45: 94-9.
23. Kanai T, Fujii T, Kozuma S, Yamashita T, Miki A, Kikuchi A, Taketani Y. Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod 2001; 7: 195-200.
24. Horuzsko A, Lenfant F, Munn DH, Mellor AL. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 2001; 13: 385-94.
25. Liang S, Baibakov B, Horuzsko A. HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 2002; 32: 2418-26.
26. Rouas-Freiss N, Kirszenbaum M, Dausset J, Carosella ED. Tolérance fœtomaternelle: rôle de la molécule HLA-G dans la protection du fœtus contre l'activité natural killer maternelle. C R Acad Sci Paris 1997; 320: 385-92.
27. Goldman-Wohl DS, Ariel I, Greenfield C, Hochner-Celnikier D, Cross J, Fisher S, Yagel S. Lack of human leucocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000; 6: 88-95.
28. Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in preeclampsia. J Immunol 1999; 163: 3491-5.
29. Rabreau M, Rouas-Freiss N, Landi M, Le Danff C, Carosella ED. HLA-G expression in trophoblast cells is independent of embryonic development. Hum Immunol 2000; 61: 1108-12.
30. Schust DJ, Hill AB, Ploegh HL. Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells. J Immunol 1996; 157: 3375-80.
31. Jun Y, Kim E, Jin M, Sung HC, Han H, Geraghty DE, Ahn K. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I molecules. J Immunol 2000; 164: 805-11.
32. Seebach JD, Comrack C, Germana S, LeGuern C, Sachs DH, DerSimonian H. HLA-Cw3 expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 1997; 159: 3655.
33. Sasaki H, Xu X-C, Mohanakumar T. HLA-E and HLA-G expression on porcine endothelial cells inhibit xenoreactive human NK cells through CD94/NKG2A-dependent and -independent pathways. J Immunol 1999; 163: 6301-5.
34. Sasaki H, Xu X-C, Smith DM, Howard T, Mohanakumar T. HLA-G expression protects porcine endothelial cells against natural killer-mediated xenogeneic cytotoxicity. Transplantation 1999; 57: 31-7.
35. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED. Implication of HLA-G molecule in heart-graft acceptance. Lancet 2000; 355: 2138.
36. Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, Dausset J, Carosella ED, Carpentier A. Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 2002; 105: 1949-54.
37. Ammor M, Creput C, Durrbach A, Samuel D, Von Ey F, Hiesse C, Droupy S, Kriaa F, Kreis H, Benoit G, Blanchet P, Bismuth H, Charpentier B. Mortality and long term outcome of combined liver and kidney transplantations. Transplant Proc 2001; 33: 1179-80.
38. Creput C, Durrbach A, Samuel D, Eschwege P, Ammor M, Kriaa F, Kreis H, Benoit G, Bismuth H, Charpentier B. Incidence of renal and liver rejection and patient survival rate following combined liver and kidney transplantations. Am J Transplant 2003; 3: 348-56.
39. Rouas-Freiss N, LeMaoult J, Moreau P, Dausset J, Carosella ED. HLA-G in transplantation: A relevant molecule for inhibition of graft rejection? Am J Transplant 2003; 3: 11-6.